Contributions of humoral and cellular immunity to vaccine-induced protection in humans.
暂无分享,去创建一个
[1] R. Ahmed,et al. From vaccines to memory and back. , 2010, Immunity.
[2] Alan D. Roberts,et al. Activation phenotype, rather than central– or effector–memory phenotype, predicts the recall efficacy of memory CD8+ T cells , 2007, The Journal of experimental medicine.
[3] N. Stollenwerk,et al. Measles Outbreaks in a Population with Declining Vaccine Uptake , 2003, Science.
[4] S. Plotkin. Why certain vaccines have been delayed or not developed at all. , 2005, Health affairs.
[5] R. Ahmed,et al. Humoral immunity due to long-lived plasma cells. , 1998, Immunity.
[6] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[7] C. Walker,et al. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. , 1993, The Journal of general virology.
[8] Luis Villarreal,et al. Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.
[9] Antonio Lanzavecchia,et al. Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.
[10] M. Slifka,et al. Public fear of vaccination: separating fact from fiction. , 2005, Viral immunology.
[11] F. Ennis,et al. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones , 1992, Journal of virology.
[12] Boris Katz,et al. The 2009 COID Recommendations for RSV Prophylaxis: Issues of Efficacy, Cost, and Evidence-Based Medicine , 2009, Pediatrics.
[13] Mark J. Shlomchik,et al. Maintenance of the plasma cell pool is independent of memory B cells , 2008, Proceedings of the National Academy of Sciences.
[14] M. Chow,et al. Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio , 2005, Journal of Virology.
[15] F. Ennis,et al. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus , 1996, Journal of virology.
[16] H. Whittle,et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal , 1995, The Pediatric infectious disease journal.
[17] E. Paoletti,et al. Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. , 1997, Virology.
[18] A. Capra,et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response , 1992, The Pediatric infectious disease journal.
[19] R. Effros,et al. Challenges for vaccination in the elderly , 2007, Immunity & Ageing.
[20] Dan R. Littman,et al. The Role of CXCR4 in Maintaining Peripheral B Cell Compartments and Humoral Immunity , 2004, The Journal of experimental medicine.
[21] Patricia W. Finn,et al. Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life , 2002, The Journal of experimental medicine.
[22] D. Watkins,et al. Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge , 2009, Journal of Virology.
[23] E. Wherry,et al. Vaccines: Effector and memory T-cell differentiation: implications for vaccine development , 2002, Nature Reviews Immunology.
[24] M. Mannie,et al. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. , 1999, Journal of immunology.
[25] H. Salman,et al. Measles vaccine failure. , 1991, Annals of Saudi medicine.
[26] M. K. Mukherjee,et al. The minimum protective level of antibodies in smallpox. , 1975, Bulletin of the World Health Organization.
[27] R. Lechler,et al. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.
[28] D. Goldblatt,et al. Immunological response to conjugate vaccines in infants: follow up study , 1998, BMJ.
[29] Hermann Wagner,et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] Deborah M. Brown,et al. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. , 2009, Cellular immunology.
[31] Anthony D. Kelleher,et al. Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.
[32] S. Plotkin,et al. 1 – A short history of vaccination , 2013 .
[33] Andreas Radbruch,et al. Chemotactic Responsiveness Toward Ligands for CXCR3 and CXCR4 Is Regulated on Plasma Blasts During the Time Course of a Memory Immune Response1 , 2002, The Journal of Immunology.
[34] C. Beadling,et al. Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity , 2006, Nature Medicine.
[35] S. Plotkin. Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.
[36] Andreas Radbruch,et al. Plasma Cell Survival Is Mediated by Synergistic Effects of Cytokines and Adhesion-Dependent Signals1 , 2003, The Journal of Immunology.
[37] S. Pierce,et al. The tipping points in the initiation of B cell signalling: how small changes make big differences , 2010, Nature Reviews Immunology.
[38] D. Maric,et al. Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide–HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections , 2003, Nature Medicine.
[39] S. Jameson,et al. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.
[40] M. Goulon,et al. [Antitetanus antibodies. Assay before anatoxinotherapy in 64 tetanus patients]. , 1972, La Nouvelle presse medicale.
[41] J. Levy,et al. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. , 1989, Journal of immunology.
[42] P. Kinchington,et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. , 1991, Journal of immunology.
[43] M. Frosch,et al. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. , 2001, Vaccine.
[44] D. Lowy,et al. Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles , 2004 .
[45] S. Nutt,et al. Terminal differentiation of lymphocytes depends on Blimp-1. , 2007, Current opinion in immunology.
[46] J. McVernon,et al. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure , 2003, Archives of disease in childhood.
[47] L. Picker,et al. Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge , 2009, Nature Medicine.
[48] Susan M. Kaech,et al. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .
[49] M. Jackson,et al. T Cells Can Use Either T Cell Receptor or Cd28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-Presenting Cells , 2000, The Journal of experimental medicine.
[50] J. Kolls,et al. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] M. Gendron,et al. HLA‐DR and ICAM‐1 Expression and Modulation in Epithelial Cells From Nasal Polyps , 2002, The Laryngoscope.
[52] Andreas Radbruch,et al. Lifetime of plasma cells in the bone marrow , 1997, Nature.
[53] I. Kurane,et al. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. , 2005, Vaccine.
[54] B. Murphy,et al. Prospects for a dengue virus vaccine , 2007, Nature Reviews Microbiology.
[55] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[56] J. Lang,et al. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. , 2010, The Journal of infectious diseases.
[57] E. Joly,et al. What is trogocytosis and what is its purpose? , 2003, Nature Immunology.
[58] Antonio Lanzavecchia,et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.
[59] M. Hilleman,et al. Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. , 1975, Pediatrics.
[60] M. Mannie,et al. Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen‐presenting cells , 1997, European journal of immunology.
[61] M. Slifka,et al. Wanted, dead or alive: new viral vaccines. , 2009, Antiviral research.
[62] H. Whittle,et al. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. , 1998, The Journal of clinical investigation.
[63] R. Bram,et al. BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.
[64] P. Matricardi,et al. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles. , 1994, Journal of immunology.
[65] B. Wiens,et al. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. , 1993, Journal of hepatology.
[66] Rate of hemolytic antibody production by single cells in vivo in rabbits. , 1974, Journal of immunology.
[67] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[68] R. Ahmed,et al. SAP is required for generating long-term humoral immunity , 2003, Nature.
[69] J. Eichberg,et al. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. , 1987, Journal of immunology.
[70] R. Noelle,et al. The immortality of humoral immunity , 2010, Immunological reviews.
[71] R. Ahmed,et al. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. , 1998, Current opinion in immunology.
[72] M Juliana McElrath,et al. Induction of immunity to human immunodeficiency virus type-1 by vaccination. , 2010, Immunity.
[73] R. Steinman,et al. Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1 , 2000, The Journal of experimental medicine.
[74] M. Birchall,et al. Differential major histocompatibility complex class II locus expression on human laryngeal epithelium , 2003, Clinical and experimental immunology.
[75] K. Schmader,et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. , 2009, The Journal of infectious diseases.
[76] P. Bongrand,et al. Intercellular transfer of antigen‐presenting cell determinants onto T cells: molecular mechanisms and biological significance , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] J. Heyse,et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection , 2002, The Pediatric infectious disease journal.
[78] G. Prince,et al. New insights for development of a safe and protective RSV vaccine , 2010, Human vaccines.
[79] K. Früh,et al. Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules1 , 2007, The Journal of Immunology.
[80] R. O. Spertzel,et al. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine , 1973, Applied microbiology.
[81] M. Jackson,et al. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. , 1999, Science.
[82] J. Cyster,et al. A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.
[83] Sheng-I Chen,et al. Single versus multi-dose vaccine vials: an economic computational model. , 2010, Vaccine.
[84] P. Lambert,et al. Can successful vaccines teach us how to induce efficient protective immune responses? , 2005, Nature Medicine.
[85] S. Plotkin,et al. Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] W. Cox,et al. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. , 2000, The Journal of infectious diseases.
[87] D. Schmid. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex. , 1988, Journal of immunology.
[88] M. Greenberg. LIVE POLIOVIRUS VACCINES , 1960 .
[89] H. Whittle,et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages , 1995, The Lancet.
[90] J. Miller,et al. AN AUTORADIOGRAPHIC STUDY OF PLASMA CELL AND LYMPHOCYTE SURVIVAL IN RAT POPLITEAL LYMPH NODES. , 1964, Journal of immunology.
[91] D. Thomas,et al. A prospective study of serum antibody and protection against smallpox. , 1972, The American journal of tropical medicine and hygiene.
[92] Taeg S. Kim,et al. The Cell Cycle Time of CD8+ T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus , 2010, PloS one.
[93] H. Whittle,et al. What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.
[94] R. Benner,et al. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. , 1981, Clinical and experimental immunology.
[95] H. Eisen,et al. The secretion of antibody by isolated lymph node cells. , 1961, The Journal of biological chemistry.
[96] K. Calame,et al. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.
[97] D. Burton. Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.
[98] L. Matter,et al. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. , 1997, The Journal of infectious diseases.
[99] T. McGaha,et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. , 2008, Blood.
[100] F. Ennis,et al. Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses1 , 2007, The Journal of Immunology.
[101] W. Lim,et al. The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers , 2003, Journal of viral hepatitis.
[102] Robert T. Chen,et al. Measles antibody: reevaluation of protective titers. , 1990, The Journal of infectious diseases.
[103] M. Slifka,et al. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity , 2010, Immunological reviews.
[104] H. Metzger,et al. Transmembrane signaling: the joy of aggregation. , 1992, Journal of immunology.
[105] B. Moss,et al. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens , 1992, Journal of virology.
[106] E. Wherry,et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.
[107] Nikhil S. Joshi,et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.
[108] H. S. Kaye,et al. Inactivated vaccines. 2. Laboratory indices of protection* , 1973 .
[109] Nikhil S. Joshi,et al. Differential Localization of Effector and Memory CD8 T Cell Subsets in Lymphoid Organs during Acute Viral Infection , 2010, The Journal of Immunology.
[110] Michael J Beach,et al. Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.
[111] P. Aichele,et al. T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections , 2010, European journal of immunology.
[112] D. Moneret-vautrin,et al. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[113] L P Skendzel,et al. Rubella immunity. Defining the level of protective antibody. , 1996, American journal of clinical pathology.
[114] Kenneth G. C. Smith,et al. Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.
[115] G. Hayden. Measles vaccine failure. A survey of causes and means of prevention. , 1979, Clinical pediatrics.
[116] O. Leo,et al. Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature. , 2008, Gynecologic oncology.
[117] A. Rosato,et al. Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer , 2010, International reviews of immunology.
[118] E. Joly,et al. Cutting Edge: CTLs Rapidly Capture Membrane Fragments from Target Cells in a TCR Signaling-Dependent Manner1 , 2001, The Journal of Immunology.
[119] M. Eibl,et al. Antibodies protect mice against challenge with tick‐borne encephalitis virus (TBEV)‐infected macrophages , 1997, Clinical and experimental immunology.
[120] Jan Holmgren,et al. Mucosal immunity and vaccines , 2005, Nature Medicine.
[121] H. Greenberg,et al. Immunity and correlates of protection for rotavirus vaccines. , 2006, Vaccine.
[122] B. Balbi,et al. Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. , 1990, American journal of respiratory cell and molecular biology.
[123] A. Casadevall. Passive antibody therapies: progress and continuing challenges. , 1999, Clinical immunology.
[124] M. Eibl. History of immunoglobulin replacement. , 2008, Immunology and allergy clinics of North America.
[125] W. Heath,et al. Cutting Edge: Central Memory T Cells Do Not Show Accelerated Proliferation or Tissue Infiltration in Response to Localized Herpes Simplex Virus-1 Infection1 , 2006, The Journal of Immunology.
[126] M. Sangster,et al. Respiratory virus infection of mice provokes a permanent humoral immune response , 1994, Journal of virology.
[127] Nichole E Carlson,et al. Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.
[128] Antonio Lanzavecchia,et al. Antigen dependent and independent mechanisms that sustain serum antibody levels. , 2003, Vaccine.
[129] A. Barrett,et al. Yellow fever vaccine , 2005, Expert review of vaccines.
[130] A. Hinman,et al. Appropriate age for measles vaccination in the United States. , 1986, Developments in biological standardization.
[131] I. Tizard. Grease, anthraxgate, and kennel cough: a revisionist history of early veterinary vaccines. , 1999, Advances in veterinary medicine.
[132] F. Klauschen,et al. SAP-controlled T-B cell interactions underlie germinal centre formation , 2008, Nature.
[133] R. Geha,et al. Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL1 , 2008, The Journal of Immunology.
[134] T. Braciale,et al. Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection1 , 2004, The Journal of Immunology.
[135] H. Hsu,et al. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. , 2003, The Journal of infectious diseases.
[136] R. Germain,et al. Acquisition of syngeneic I-A determinants by T cells proliferating in response to poly (Glu60Ala30Tyr10). , 1981, Journal of immunology.
[137] D. Rock,et al. Genome of Horsepox Virus , 2006, Journal of Virology.
[138] B. Bell. Hepatitis A vaccine. , 2002, Seminars in pediatric infectious diseases.
[139] H. Eisen,et al. Observations on the mechanism of secretion of gamma-globulins by isolated lymph node cells. , 1962, The Journal of biological chemistry.
[140] R. Ahmed,et al. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.
[141] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[142] T. McKeithan,et al. Peptide-Specific Intercellular Transfer of MHC Class II to CD4+ T Cells Directly from the Immunological Synapse upon Cellular Dissociation1 , 2005, The Journal of Immunology.
[143] R. Ahmed,et al. Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.
[144] R. Welsh,et al. Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection1 , 2005, The Journal of Immunology.
[145] Hyun-Dong Chang,et al. Organization and maintenance of immunological memory by stroma niches , 2009, European journal of immunology.
[146] S. Kaech,et al. Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.
[147] M. Leandro,et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[148] M. Slifka,et al. Longevity of T-cell memory following acute viral infection. , 2010, Advances in experimental medicine and biology.
[149] D. Jelinek,et al. Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation1 , 2007, The Journal of Immunology.
[150] D. Romberger,et al. Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells. , 2000, International journal of immunopharmacology.
[151] P. Schneider,et al. Cracking the BAFF code , 2009, Nature Reviews Immunology.
[152] J. Whitton,et al. Tentative T Cells: Memory Cells Are Quick to Respond, but Slow to Divide , 2008, PLoS pathogens.
[153] Samuel L. Groseclose,et al. Summary of Notifiable Diseases, United States. , 1997 .
[154] I. Messaoudi,et al. Protective immunity following vaccination: How is it defined? , 2008, Human vaccines.
[155] A. Nussbaum,et al. The Regulation and Maturation of Antiviral Immune Responses , 2004, Advances in Virus Research.
[156] Thomas F. Tedder,et al. Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice1 , 2008, The Journal of Immunology.
[157] David C. Johnson,et al. Human Cytomegalovirus US2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003, Journal of Virology.
[158] L. Lefrançois. Development, trafficking, and function of memory T‐cell subsets , 2006, Immunological reviews.
[159] F. Fenner. Smallpox and its eradication , 1988 .
[160] Edward Jenner,et al. An inquiry into the causes and effects of the Variolæ vaccinæ, 1798 , 1966 .